AI assistant
INSMED Inc — Director's Dealing 2018
Oct 2, 2018
30150_dirs_2018-10-02_af796cf5-6b2f-4eb0-b15f-563b9b16c4f5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2018-09-28
Reporting Person: Lewis William (Director, President & CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-09-28 | Stock Option | $12.44 | A | 83333 | Acquired | 2023-05-23 | Common Stock (83333) | Direct |
Footnotes
F1: On May 23, 2013, the reporting person was granted an option to purchase 166,667 shares of common stock. The option vests in two installments based upon the Issuer's satisfaction of two separate performance metrics. The first installment vested on February 26, 2015. The performance metric applicable to the second installment, the first written approval of a New Drug Application or Marketing Authorization Application from the Food and Drug Administration of European Medicines Agency, respectively, was met on September 28, 2018, resulting in the vesting of the second installment.